Clinical Report: LensOne Heads Toward Pivotal Trial
Overview
The LensOne prosthetic capsular bag is under evaluation in the upcoming GOLDEN GATE trial, which aims to assess its performance in a multicenter prospective setting.
Background
The management of aphakia or dislocated intraocular lenses (IOLs) is a significant challenge in ophthalmology, particularly in eyes lacking capsular support. Traditional approaches include various fixation techniques.
Data Highlights
No numerical data provided in the source material.
Key Findings
- The LensOne prosthetic capsular bag shows a safety and efficacy profile.
- It demonstrates minimal tilt and decentration of lenses.
- Performance of the LensOne device is comparable to in-the-bag phaco techniques.
- The GOLDEN GATE trial is set to begin this fall as a multicenter prospective pivotal trial.
- Long-term safety follow-up data has been established for the prosthetic capsular bag.
Clinical Implications
The initiation of the GOLDEN GATE trial will be critical in validating these early results in a larger population.
Conclusion
Further evaluation of the LensOne prosthetic capsular bag is pending from the upcoming pivotal trial.
Related Resources & Content
- Retinal Physician, SUBSPECIALTY NEWS, 2022 -- FDA approves Cimerli, GATHER2 GA trial meets primary endpoint, and more.
- Retinal Physician, Axpaxli Superior to Aflibercept in Wet AMD Trial, 2026 -- Data from the phase 3 SOL-1 trial.
- Ophthalmology Management, Clearside Biomedical Reports Successful End of Phase 2 Meeting With FDA for CLS AX, 2025 -- Key elements for proposed phase 3 trials.
- Ophthalmology Management, Atsena Therapeutics Announces Alignment with FDA on Regulatory Pathway to Approval for ATSN201 in XLRS, 2025.
- European Society of Cataract and Refractive Surgeons -- Modern management of aphakia or dislocated IOLs.
- BMC Ophthalmology, Visual outcome, safety, and complications of iris suture fixation versus iris claw fixation for aphakic correction, 2026 -- A prospective randomized study.
- Retinal Physician, Pivotal Trial Begins for LensOne Device, 2026.
- https://www.escrs.org/media/ooama3sf/full-extended-guideline-24092025.pdf
- Visual outcome, safety, and complications of iris suture fixation versus iris claw fixation for aphakic correction: a prospective randomized study | BMC Ophthalmology | Springer Nature Link
- Pivotal Trial Begins for LensOne Device | Retinal Physician
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
